$92.42
1.25% yesterday
NYSE, Dec 30, 10:10 pm CET
ISIN
US29261A1007
Symbol
EHC

Encompass Health Corporation Target price 2024 - Analyst rating & recommendation

Encompass Health Corporation Classifications & Recommendation:

Buy
93%
Hold
7%

Encompass Health Corporation Price Target

Target Price $116.50
Price $92.42
Potential
Number of Estimates 12
12 Analysts have issued a price target Encompass Health Corporation 2025 . The average Encompass Health Corporation target price is $116.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 13 Analysts recommend Encompass Health Corporation to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Encompass Health Corporation stock has an average upside potential 2025 of . Most analysts recommend the Encompass Health Corporation stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 4.80 5.35
10.41% 11.42%
EBITDA Margin 20.95% 20.24%
4.25% 3.37%
Net Margin 7.29% 8.11%
16.40% 11.32%

12 Analysts have issued a sales forecast Encompass Health Corporation 2024 . The average Encompass Health Corporation sales estimate is

$5.3b
Unlock
. This is
2.58% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.4b 2.85%
Unlock
, the lowest is
$5.3b 2.19%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $4.8b 10.41%
2024
$5.3b 11.42%
Unlock
2025
$5.8b 8.92%
Unlock
2026
$6.3b 8.51%
Unlock
2027
$6.7b 6.04%
Unlock
2028
$7.2b 7.32%
Unlock

12 Analysts have issued an Encompass Health Corporation EBITDA forecast 2024. The average Encompass Health Corporation EBITDA estimate is

$1.1b
Unlock
. This is
2.78% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.1b 2.29%
Unlock
, the lowest is
$1.1b 3.12%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $1.0b 15.09%
2024
$1.1b 7.67%
Unlock
2025
$1.2b 8.69%
Unlock
2026
$1.3b 8.66%
Unlock
2027
$1.3b 4.00%
Unlock
2028
$1.4b 6.14%
Unlock

EBITDA Margin

2023 20.95% 4.25%
2024
20.24% 3.37%
Unlock
2025
20.20% 0.20%
Unlock
2026
20.23% 0.15%
Unlock
2027
19.84% 1.93%
Unlock
2028
19.62% 1.11%
Unlock

6 Encompass Health Corporation Analysts have issued a net profit forecast 2024. The average Encompass Health Corporation net profit estimate is

$434m
Unlock
. This is
3.94% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$442m 5.80%
Unlock
, the lowest is
$422m 1.21%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $350m 28.52%
2024
$434m 24.01%
Unlock
2025
$506m 16.63%
Unlock
2026
$563m 11.36%
Unlock
2027
$533m 5.34%
Unlock
2028
$561m 5.29%
Unlock

Net Margin

2023 7.29% 16.40%
2024
8.11% 11.32%
Unlock
2025
8.68% 7.03%
Unlock
2026
8.91% 2.65%
Unlock
2027
7.95% 10.77%
Unlock
2028
7.80% 1.89%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 3.47 4.30
28.52% 23.92%
P/E 21.75
EV/Sales 2.38

6 Analysts have issued a Encompass Health Corporation forecast for earnings per share. The average Encompass Health Corporation <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$4.30
Unlock
. This is
3.86% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$4.38 5.80%
Unlock
, the lowest is
$4.19 1.21%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $3.47 28.52%
2024
$4.30 23.92%
Unlock
2025
$5.02 16.74%
Unlock
2026
$5.59 11.35%
Unlock
2027
$5.29 5.37%
Unlock
2028
$5.57 5.29%
Unlock

P/E ratio

Current 22.59 17.60%
2024
21.75 3.72%
Unlock
2025
18.65 14.25%
Unlock
2026
16.75 10.19%
Unlock
2027
17.69 5.61%
Unlock
2028
16.80 5.03%
Unlock

Based on analysts' sales estimates for 2024, the Encompass Health Corporation stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.45 13.95%
2024
2.38 2.68%
Unlock
2025
2.19 8.19%
Unlock
2026
2.02 7.84%
Unlock
2027
1.90 5.69%
Unlock
2028
1.77 6.82%
Unlock

P/S ratio

Current 1.81 25.97%
2024
1.76 2.51%
Unlock
2025
1.62 8.19%
Unlock
2026
1.49 7.84%
Unlock
2027
1.41 5.69%
Unlock
2028
1.31 6.82%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today